Patterns of aortic dilatation in bicuspid aortic valve-associated aortopathy.

J Am Soc Echocardiogr

Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Published: June 2013

Background: Bicuspid aortic valves (BAVs) are associated with aortopathy. Recent studies suggest that aortic dilatation is more likely to be seen with left-right coronary cusp fusion (type I) compared with right-noncoronary cusp fusion (type II). The aim of this study was to investigate the association between BAV morphology and patterns of aortopathy.

Methods: Aortic dimensions and BAV morphology were obtained retrospectively from archived cine loops of 581 consecutive patients with BAVs and 277 matched normal controls from the Vancouver General Hospital echocardiography database. Patient demographics and other echocardiographic parameters were extracted from the database.

Results: The study population was composed of 71% type I BAVs (415 patients) and 26% type II BAVs (149 patients). Aortic dilatation was present in 30% of the population. Type I BAV was associated with increased dimensions indexed to body surface area at the sinus of Valsalva compared with type II BAV. No difference in proximal ascending aortic dimension was seen between different BAV morphologies. The pattern of dilatation with type I BAV was more likely to be at the level of the annulus or sinus of Valsalva compared with type II BAV (62% vs 33%, P= .002). Type I BAV was an independent predictor of proximal aortic dilatation (odds ratio, 3.42; 95% confidence interval, 1.07-10.9).

Conclusions: Type I BAV is associated with a greater likelihood of dilatation at the annulus and sinus of Valsalva. There is relative sparing of this region of the aorta in patients with type II BAVs. Individuals with different BAV morphologies may require different strategies of aortopathy surveillance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2013.02.017DOI Listing

Publication Analysis

Top Keywords

type bav
24
aortic dilatation
16
type bavs
12
sinus valsalva
12
type
11
bav
10
bicuspid aortic
8
cusp fusion
8
fusion type
8
bav morphology
8

Similar Publications

Recurrent strokes after transcatheter aortic valve replacement in an elderly patient with severe bicuspid aortic valve stenosis: a case report.

BMC Cardiovasc Disord

December 2024

Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, 100730, China.

Background: Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Recently, its use has also been extended to low-risk patients, resulting in its increasing utilization in patients with bicuspid aortic valve (BAV). But as a serious post-TAVR complication, ischemic stroke was associated with a nearly 6-fold increased 30-day mortality.

View Article and Find Full Text PDF

Clinical outcomes of patients with bicuspid aortic valve undergoing a targeted transcatheter aortic valve replacement approach: the LIRA Method.

Can J Cardiol

December 2024

Interventional Cardiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Division, Ospedale Maggiore, Bologna, Italy; Cardiovascular Imaging Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Experimental Imaging Center, IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.

Background: Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic valve (BAV) disease is still burdened by a non-negligible rate of stroke and permanent pacemaker implantation (PPI). These suboptimal results, possibly related to the unique BAV anatomy, might suggest the use of a different sizing method in this setting. The aim of our study is to evaluate whether the application of the supra-annular LIRA method might improve clinical outcomes in this population.

View Article and Find Full Text PDF

Objectives: The bicuspid aortic valve (BAV) is the most common congenital heart defect. Patients with BAV frequently develop aortopathy, which depends on the dysfunction and morphotype of the BAV.

Aim: The aim of our study was to compare the echocardiography and cardiac magnetic resonance (CMR) findings in BAV patients, and to define the risks of BAV dysfunction and aortopathy.

View Article and Find Full Text PDF

Chemical and Heat Treatment for Viral Inactivation in Porcine-Derived Gelatin.

BMC Biotechnol

December 2024

Biomedical Department, R&D Center, Nitta Gelatin Inc, 2-22, Futamata, Yao City, Osaka, 581-0024, Japan.

Article Synopsis
  • - The study focuses on evaluating the effectiveness of virus inactivation methods used in the manufacturing process of porcine-derived gelatin, which is commonly used in pharmaceuticals and medical devices.
  • - Researchers tested various model viruses and found that both chemical and heat treatments significantly reduced viral presence, achieving a log reduction value (LRV) greater than 4, indicating effective inactivation.
  • - The findings confirm that implementing these treatment steps in gelatin production enhances safety by minimizing potential viral contamination in biomedical applications.
View Article and Find Full Text PDF

A congenitally malformed aortic valve, unicuspid (UAV), or bicuspid (BAV), occurs in about 1% of the population and is known to be more frequent in patients with aortic dissection. The clinical and operative findings in a series of 134 patients with spontaneous, acute type A aortic dissection were studied, comparing patients with normal and abnormal aortic valve morphology. The aortic valve was normal in 123 of 134 (92%) patients and abnormal in 11 of 134 (8%) patients: BAV in 10 of 134 (7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!